Reata Pharmaceuticals Inc. Company Name:
RETA Stock Symbol:
NASDAQ Market:
Reata Pharmaceuticals Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
-
IRVING, Texas, Oct. 11, 2019 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a clinical-stage biopharmaceutical company, today announced that three abstracts highlighting clinical and nonclinical data for bardoxolone methyl (bardoxolone) will be presented at the American Soc...
-
Reata Pharmaceuticals (NASDAQ: RETA ) has reacquired development and commercialization rights to its Nrf2 activator product platform from licensee AbbVie (NYSE: ABBV ). Specifically, it owns exclusive global rights bardoxolone methyl, omaveloxolone and all other next-generation Nrf2 activa...
-
IRVING, Texas, Oct. 10, 2019 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a clinical-stage biopharmaceutical company, today announced the reacquisition of development, manufacturing and commercialization rights concerning its proprietary Nrf2 activator product platform or...
RETA Articles, Reata Pharmaceuticals Inc.
home / stock / reta / reta articles
No one has written and article on Reata Pharmaceuticals Inc., stock symbol RETA. Be the first to contribute and write an article.
